Granisetron is an indazole derivative with antiemetic properties.
As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
| Product Name |
Granisetron Base |
| CAS Number |
109889-09-0 |
| Therapeutic Class |
Serotonin (5-HT3) receptor antagonist, Antiemetic |
| Dosage Form |
Transdermal Patch, Extended-Release Injection for Subcutaneous use |
| Availability |
Commercial |
| Regulatory Status |
USDMF |